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RHOB promoter polymorphisms cooperate in regulating RHOB
transcriptional activity and thus chondrocyte apoptosis whereby
an increase in chondrocyte apoptosis is predicted to result in the
net loss of articular cartilage.
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TRANSFORMING GROWTH FACTOR-β IN
MESENCHYMAL STEM CELLS FROM OSTEOARTHRITIS
PATIENTS
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Purpose: Chondrogenic differentiation by mesenchymal stem
cells (MSCs) is associated with cytokines such as transforming
growth factor-β (TGF-β). This investigation was conducted to
examine the gene expression of the three isoforms of TGF-β
(1,2,3) and their receptors (TBR-I, TBR-II, TBR-III) in primary
MSCs culture established from bone marrow from patients with
end-stage osteoarthritis (OA).
Methods: MSCs were prepared from bone marrow aspirates
obtained from 18 patients undergoing joint replacement as a
result of OA and from 10 healthy donors. Total RNA was ex-
tracted from primary MSCs culture established from these cells
and quantitative real time reverse-transcription-polymerase chain
reaction was performed. Specific primers sequences of TGF-β
isoforms and their receptors, and rRNA18S, as internal control,
were used in this study. Shapiro-Wilk test was used to study the
normality of variables. Data are reported either as normalization
ratio (NR) mean ± SD in normal conditions or as NR median and
percentiles (percentile 25-percentile 75) if the variables did not fit
a Gaussian distribution. Normal variables were compared using
Student’s t test and non-normal variables using Mann-Whitney U
tests. P values less than 0.05 were considered significant.
Results: Compared to controls, total TGF-β mRNA expression
significantly increased in MSCs from OA patients. In relation to
TGF-β isoforms, only TGF-β1 showed a significant increase on
the expression in MSCs. TBR-I showed no significant change
between groups; however, both TBR-II and TBR-III increased
significantly in MSCs from OA patients compared with controls.
Data are summarized in table:
Gene expression of TGF-β, isoforms and receptors, in MSCs of OA patients
Gene NR OA patients NR controls p
TGF-β 0.61±0.28 0.40±0.24 0.042
TGF-β1 2.07±0.99 1.20±1.05 0.036
TGF-β2 2.25 [0.78-5.34] 2.94 [0.78-6.44] 0.982
TGF-β3 18.13 [11.20-27.29] 14.54 [0.35-25.5] 0.734
TBR-I 0.17 [0.05-0.76] 0.11 [0.06-0.31] 0.441
TBR-II 0.17 [0.08-0.26] 0.05 [0.02-0.06] 0.001
TBR-III 0.18 [0.07-1.38] 0.06 [0.03-0.35] 0.021
Conclusions: These results indicate that primary MSCs culture
established from patients with OA show an up-regulation on the
expression of total TGF-β, isoform TGF-β1, TBR-II and TBR-III
receptors. This response may be at the basis of inefficient wound
repair in cartilage in OA. Further studies should address the
possible involvement of the TGF-β1/TBRII and TBR-III system in
the pathophysiology of OA.
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FURTHER EVIDENCE FOR A ROLE OF FRIZZLED
RELATED PROTEIN 3 GENE POLYMORPHISMS IN
GENERALIZED OSTEOARTHRITIS SPECIFICALLY IN
WOMEN
A. Gonzalez, J. Rodriguez-Lopez, M. Pombo-Suarez, M. Liz,
Y. Lopez-Golan, J.J. Gomez-Reino
Hospital Clinico Universitario de Santiago, Santiago de
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Purpose: To confirm previous studies showing association of friz-
zled related protein 3 (FRZB) non-synonymous polymorphisms
with hip OA in women or with generalized OA, and to explore
possible involvement in other OA phenotypes.
Methods: A case-control study was done with three groups of
Spanish OA patients: patients that had undergone total joint
replacement for primary OA in the hip, THR (n = 310), or the
knee, TKR (n = 277) and patients with hand OA according to
the ACR classification criteria, HOA (n = 242). All patients were
specifically questioned and explored and their clinical records
were reviewed regarding the involvement of other joint regions.
Controls were more than 55 years old and were selected because
they did not show clinical OA symptoms (n = 294). SNPs resulting
in R200W (rs288326) and in R324G (rs7775) substitutions in
exons 4 and 6 of FRZB, respectively, were genotyped with
fluorogenic 5’ nuclease assays (TaqMan, AppliedBiosystems).
Results: There were not significant differences in allele frequen-
cies of any of the two SNPs between controls and each of the
three groups of OA patients. These results were not modified
by stratifying according to sex, or by pooling all OA patients in
a single group, or by considering genotypes at the two SNPs
jointly. However, allele G of the R324G SNP showed a trend
to higher frequency in patients with OA at multiple joints (p =
0.07). This trend was restricted to female patients (p = 0.10) and
more specifically to the subgroup of women in the THR group
(8.3% in patients without other affected joints versus 16.2% in
patients with them, p = 0.04). The increase in G allele frequency
was more marked in those patients showing a larger number of
OA affected joint regions (13.1% with one, 15.9% with two and
24.1% with more than two additionally affected joints, p = 0.006
for the trend).
Conclusions: These results add further evidence indicating that
the non-synonymous SNP in exon 6 of the FRZB gene play a role
in the development of OA. They suggest a subphenotype where
the effect could be clearer: female patients with polyarticular OA
and severe involvement of the hip joint. If this subphenotype
is confirmed with additional studies it will be compatible with
previous results that have found either association with hip OA
in females or with generalized OA in both sexes.
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NURR1 EXPRESSION IS INCREASED IN
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CYTOKINE AND METALLOPROTEINASE GENE
TRANSCRIPTION: A DOWNSTREAM ACTION OF
CYCLOOXYGENASE 2-DERIVED PGE2
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Purpose: Osteoarthritic chondrocytes produce multiple cy-
clooxygenase and lipoxygenase products, predominantly
prostaglandin (PG) E2, which in turn affect chondrocyte phe-
notype. We report here the effects of PGE2 on the expres-
sion/activity of NURR1, an immediate early gene and member of
the nuclear receptor superfamily.
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Methods: Cartilage explants were prepared from OA patients
undergoing joint replacement surgery. Chondrocytes were iso-
lated using collagenase digestion and cultured in monolayer.
Prostaglandin E2 (PGE2), IL-6 and IL-8 production were esti-
mated using radioimmunoassay and ELISA respectively. Gene
expression studies of cartilage from normal and OA patients were
performed using Affymetrix U95Av2 microarray. The expression
of various genes was performed using TaqMan Real time-PCR.
Results: We studied NURR1 mRNA expression in cartilage and
synovium from 18 OA patients vs. 8 age-matched normal con-
trols, using Affymetrix microarray. Specimens were obtained at
the time of joint replacement surgery (OA) or from accident vic-
tims (normal). Relative to normals, NURR1 was overexpressed
in OA cartilage (2-5 folds) and synovium (2 fold). Increased ex-
pression of NURR1 in OA cartilage and synovium was confirmed
by real time PCR. Incubation of OA chondrocytes with PGE2
(10uM) induced NURR1 expression (20-50 fold), as analyzed by
TaqMan PCR. IL-1 (10ng/ml) also induced NURR1 expression,
yielding biphasic peaks at 1h and 24h. IL-1 induced NURR1
expression was augmented by addition of exogenous PGE2.
IL-1-induced expression of NURR1 was inhibited by celecoxib
(2uM) and EP4 receptor antagonist (A23858), indicating that IL-
1 induced NURR1 expression depends upon COX-2 expression
and PGE2 generation. PGJ2, a potent inhibitor of NFkB acti-
vation, did not induce NURR1 expression. PGE2 acts via EP
receptors to stimulate adenylyl cyclase and cAMP generation;
cAMP analog dibutyryl cAMP stimulated NURR1 expression,
consistent with a role for cAMP in PGE2 upregulation of NURR1.
Since NURR1 binds to the NURR1 cis- acting sequence (NBRE)
in the promoter region of a variety of genes, we examined
the effect of adenoviral-mediated over-expression of NURR1 in
chondrocytes. Chondrocytes transfected with NURR1 exhibited
increased mRNA expression (by qPCR) and protein synthesis
(by ELISA) of IL-6, IL-8 and MMP-13, and decreased expression
of MMP-1. These effects were duplicated by addition of PGE2 to
non-transfected chondrocyte which could be significantly blocked
by EP4 receptor antagonist.
Conclusions: NURR1 is over-expressed in OA cartilage and
synovium. Our data suggest that NURR1 upregulation results
from cytokine (e.g., IL-1)-induced, COX-2-dependent PGE2 pro-
duction. NURR1 expression regulates chondrocyte gene acti-
vation in vitro, and in vivo may account for disease-associated
downstream actions of COX-2-derived PGE2.
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Purpose: Osteoarthritis (OA) is the most common bone and
joint disease with considerable genetic determinant. To clarify
the etiology and pathogenesis of OA, we have been working on
the identification of susceptibility gene for OA. The aim of the
study is to report association of asporin with OA together with its
function, mechanism of action and regulation.
Methods: A large-scale candidate gene-association study was
performed for OA of the knee and hip joints in Japanese us-
ing several independent cohorts including a total of more than
1,500 subjects. Susceptibility genes were located by a linkage-
disequilibrium mapping. The association of an identified gene,
asporin was tested by meta-analysis by literature using subse-
quent reports in other ethnic groups. The function, mechanism
of action and regulation of asporin were examined by molecular,
cellular, imuno-histochemical and immnuno-cytochemical anal-
yses using ATDC5, a mouse model for chondrogenesis and
human cartilage cells as well as OA samples.
Results: We found that a functional polymorphism in the asporin
gene that encodes asparatic-acid (D) repeat is significantly as-
sociated with knee and hip OA in Japanese. The D14 allele was
over-represented in OA. The association was replicated in other
ethnic groups by the meta-analysis. Asporin binds to TGF-β, a
key cytokine in chondrogenesis and pathogenesis of OA, and
inhibits TGF-β-induced chondrogenesis. Asporin inhibited early
and late stages of chondrogenesis. It also inhibited expressions
of cartilage matrix genes and chondrocyte phenotypes induced
by TGF-β1. Knockdown of asporin by RNAi increased expres-
sions of cartilage matrix genes and TGF-β1, and TGF-β1 induced
asporin mRNA in turn. Asporin inhibited Smad phosphorylation
and reporter gene transactivation induced by TGF-β, but did not
inhibit TGF-β/Smad signaling after TGF-β type I receptor activa-
tion. Asporin co-localized to TGF-β1 in cell surface and inhibited
TGF-β binding to TGF-β type II receptor in vivo.
Conclusions: Asporin regulates the canonical TGF-β signal by
inhibiting the binding of TGF-β to its receptor through direct
interaction on cell surface. Our results suggest asporin plays a
critical role in molecular pathogensis of OA.
P245
HAPLOTYPES OF THE C REACTIVE PROTEIN GENE
ASSOCIATE IN THE GARP STUDY TO SERUM C
REACTIVE PROTEIN AND THE OCCURRENCE OF
OSTEOARTHRITIS IN THE HAND
S.D. Bos, E. Suchiman, M. Kloppenburg, H.M. Kroon,
E. Slagboom, I. Meulenbelt
LUMC, Leiden, The Netherlands
Purpose: C-reactive protein (CRP) is the prototypical protein up
regulated in the acute phase response. Recently in a population
based study, a series of genetic haplotypes was described on
the basis of 7 SNPs. In this study three groups of haplotypes
were identified that associated to high, medium or low serum
CRP levels in Caucasians, respectively. High CRP levels have
previously been reported to associate to erosive osteoarthritis of
the hand (EOA).
We explored whether these haplotypes associated to serum CRP
in OA patients. More importantly we explored in this (GARP)
study whether these haplotypes associated to the occurrence of
OA at multiple joints in the hands only and to generalized OA
expressed in different joint groups.
Methods: The GARP study consists of 191 (n=382) Caucasian
sibling pairs with early onset OA at multiple joint sites. A ra-
diographic score per joint site is interpreted as a quantitative
score for OA severity. The SNPs described to build up the hap-
lotypes were genotyped in the GARP study by use of mass
spectrometry-based hME assay (Sequenom). The haplotypes
were reconstructed using the algorithm based program THE-
SIAS. For applying t-test statistics and logistic regression analy-
sis we used SPSS version 11 software (SPSS, Chicago, IL).
Results: The haplotyped individuals for which a serum CRP
level was available (n=351) showed similar relative frequencies
and serum CRP as observed previously and we indeed noted
significant associations between haplotypes and CRP levels as
observed previously. The haplotype associated to higher serum
CRP levels was significantly associated to the presence of hand
OA at multiple joints (>7) as measured by radiographic fea-
tures.
Conclusions: In the GARP study we have no score available
for erosive OA and therefore it remains unclear whether the
association can be assigned to EOA or is caused by generalized
nodular hand OA. No association was found for the generalized
OA definition involving multiple joint groups. Our study indicates
that the role of CRP in the development of hand OA may not
be limited to erosive OA only but also to generalized hand OA
